AIDPORT Sp. zo.o.

Skórzewo 60-185

5 studies enrolling now · 6 studies all time

What they study most

Carcinoma, Transitional Cell, Chronic Lymphocytic Leukemia, Leukemia, B-cell, Leukemia, Lymphocytic, Multiple Myeloma, Muscle-invasive Urothelial Carcinoma, Neoplasm Metastasis, Plasma Cell Disorder, Small Lymphocytic Lymphoma, Urinary Bladder Neoplasms, Urinary Incontinence,Stress

Studies at this site

• A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight — Recruiting now
• Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma — Recruiting now
• A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Recruiting now
• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now
• A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC) — Running, not enrolling